市場調査レポート

商品コード

変形性関節症治療 - 市場規模と予測、世界および地域のシェア、動向、成長機会分析レポート：治療タイプ別、適応疾患別、エンドユーザー別、地域別

Osteoarthritis Therapy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, Disease Indication, End User, and Geography

出版日: 2024年02月02日 | 発行: The Insight Partners

| ページ情報: 英文 199 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 5,190 815,556円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 7,190 1,129,836円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 9,190 1,444,116円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

変形性関節症治療の市場規模は、2022年の173億6,000万米ドルから2030年には306億8,000万米ドルに成長すると予測されており、2022～2030年のCAGRは7.4%を記録すると予測されています。変形性関節症の有病率の上昇と、薬への依存を減らす革新的な治療オプションが、変形性関節症治療市場を推進する主な要因です。しかし、製品回収が変形性関節症治療市場の成長を阻害しています。さらに、変形性関節症療法を促進する、より効果的な治療オプションは、予測期間中、有利な市場動向として機能します。

成長の促進要因

変形性関節症の有病率の上昇が変形性関節症療法市場の成長を牽引

CDCの報告書によると、OAには世界全体で5億人以上が罹患しており、世界人口の7%を占めています。長期障害の主な原因となっています。変形性関節症は、スポーツ選手や関節に怪我や外傷を負った人に多く見られます。さらに、女性に多く、世界の変形性関節症患者の60％を占めています。

世界保健機関（WHO）の報告によると、変形性関節症は高齢者により多くみられます。また、変形性関節症は誰でも罹患する可能性があるが、40歳以上の成人に最も多く見られる疾患です。また、WHOの報告によると、人口の約73％が55歳以上の高齢者であり、そのうち60％が女性です。米国疾病予防管理センター（CDC）の報告によると、米国では3,250万人以上の成人がOAに罹患しています。このように、OAの有病率の上昇に伴い、生物学的療法のような新しい治療法が世界的に注目されています。血小板を豊富に含む血漿（PRP）療法は、有望なOA治療法として登場した一例です。PRPは、身体の自然治癒と組織修復プロセスを触媒することで、組織の回復を促進します。

レポート区分と調査範囲：

変形性関節症治療市場は、治療タイプ、適応疾患、エンドユーザーに区分されます。治療タイプに基づき、市場は経皮的電気神経刺激療法（TENS）、作業療法、理学療法、多血小板血漿（PRP）療法および間質血管分画、プロロセラピー、その他に区分されます。市場は疾患適応症別に、変形性膝関節症、変形性脊椎症、変形性足関節症、変形性肩関節症、変形性手関節症、その他に区分されます。エンドユーザー別では、市場は病院・クリニック、専門クリニック、外来手術センター（ASC）、在宅医療、その他に区分されます。

治療タイプ別の洞察

治療タイプ別に見ると、変形性関節症治療市場は経皮的電気神経刺激（TENS）、作業療法、理学療法、多血小板血漿・間質血管分画、プロロセラピー、その他に区分されます。理学療法分野は、2022年の変形性関節症治療市場の治療タイプ別セグメントで最大の市場シェアを占めました。その他セグメントは予測期間中、最も速いCAGR 7.5％で成長すると予測されています。2022年の変形性関節症治療市場において、理学療法分野が治療タイプ別分野で最大の市場シェアを占めました。その他のセグメントは予測期間中、最も速いCAGR 7.5％で成長すると予測されています。ヨガなどの物理療法は、変形性膝関節症に罹患した患者の身体機能の改善に役立ちます。臨床研究では、理学療法（PT）を受けている変形性膝関節症の患者は、グルココルチコイド注射を受けている患者よりも質調整生存年（QOL）が高いことが明らかになっています。さらに、理学療法はグルココルチコイド注射よりも臨床的に効果的であり、より費用対効果の高い選択肢として認識されています。

変形性関節症治療市場では、その他の分野が最も高いCAGRを記録すると推定されています。もう1つの治療法は、変形性関節症に対するリハビリテーション療法です。リハビリテーション・プログラムは、痛みを軽減し、機能性を素早く向上させるように設計されています。リハビリの主な目的は、膝OAの症状を和らげ、進行を遅らせることです。将来的な展望とリハビリテーションには、OAの非薬理学的管理に続いて、生活の質、関節機能、筋力、筋力、機能的パフォーマンスを効果的に改善する運動が含まれます。したがって、リハビリテーションプログラムの修正は、最終的に患者の変形性関節症の痛みを軽減し、予測期間中の変形性関節症治療市場の成長を強化します。

疾患ベースの洞察

変形性膝関節症セグメントは、2022年の変形性関節症治療市場において疾患適応症セグメント別で最大の市場シェアを占めており、同セグメントは予測期間中に7.7%のCAGRで最速の成長を遂げると予測されています。米国科学アカデミーの報告書によると、変形性膝関節症（KO）は疾病負担全体の80％以上を占め、45歳以上の米国成人の約19％が毎年罹患しています。メーカーによる革新的な製品の発売は、変形性膝関節症の負担軽減に役立ちます。2021年9月、Contura International Ltdは、膝OAに伴う痛みを緩和するための、安全で効果的、長時間作用型で低侵襲な治療法に対するアンメット・クリニカル・ニーズを満たす、現行療法に代わる新製品「Arthrosamid」の発売を発表しました。したがって、膝OAの有病率の上昇と変形性関節症の痛みを最小限に抑える革新的な製品の発売が、変形性関節症治療市場の成長を牽引しています。

エンドユーザーに基づく洞察

2022年の変形性関節症治療市場のエンドユーザーセグメント別市場シェアは、在宅ケアセグメントが最大でした。また、病院・診療所セグメントは、予測期間中に7.5%の最高CAGRを記録すると予測されています。関節炎を克服するための第一の治療法は、余分な体重を減らすことです。さらに、温熱療法や寒冷療法は、硬くなった関節に柔軟性を取り戻し、関節痛を軽減するのに役立ちます。電気毛布や湿熱パッドの使用は、痛みの軽減に役立つことが証明されています。しかし、氷のパックや凍らせた野菜の袋などの冷たい治療法を患部の関節に適用することで、痛みを和らげることができます。このような治療オプションが利用できることは、変形性関節症を自宅で管理するための成功した治療法であることを証明しており、これがホームケア・セグメントの変形性関節症治療市場の成長を牽引しています。

地域別分析：

地域別に見ると、世界の変形性関節症治療市場は北米、欧州、アジア太平洋、中南米、中東・アフリカに区分されます。2022年、変形性関節症治療の世界市場シェアは北米が最大でした。アジア太平洋は2022～2030年に最も高いCAGRを記録すると予想されています。北米市場では、米国が変形性関節症治療市場で最大の市場シェアを占めています。米国疾病予防管理センター（CDC）の報告書で明らかにされた統計によると、変形性関節症（OA）は最も一般的な関節炎であり、米国では3,250万人の成人が罹患しています。また、Osteoarthritis（OA）Action Allianceの報告書によると、米国におけるOAに関連する経済的負担は全体で年間1,368億米ドルと推定されています。さらに、米国レントゲン光線学会（ARRS）の報告書によると、OAの生涯リスクは50％であり、2040年までに米国内の成人の7,800万人（26％）がOAに罹患すると推定されています。

さらに、OA疼痛に対する非薬物療法を目指すメーカーによる新製品の承認は、変形性関節症治療市場の成長に影響を与えます。2021年6月、CyMedica Orthopedics社は、変形性膝関節症の痛みに対する非侵襲的治療法である「Intellihab System」のFDA承認を取得したと発表しました。この新製品発売は、衰弱性変形性関節症疾患を伴うOA疼痛を治療するために設計された、治療的かつデジタルベースのエコシステムです。したがって、OA治療における治療薬への依存を減らすことを意図した新しい非薬物療法は、予測期間中の変形性関節症治療市場の成長を促進すると思われます。

変形性関節症治療市場- 主な市場力学
市場促進要因
- 変形性関節症の有病率の上昇
- 革新的な治療オプションによる薬物依存の軽減
市場抑制要因
- 製品回収
市場機会
- 再生医療の利用可能性
今後の動向
- より効果的な治療オプション
促進要因と抑制要因の影響

第6章変形性関節症治療市場：世界市場分析

変形性関節症治療市場の収益、2022-2030年
- 変形性関節症治療市場の収益、2022年～2030年

第7章変形性関節症治療市場分析：治療タイプ別

経皮的電気神経刺激療法（TENS）
作業療法
理学療法
血小板リッチ血漿療法と間質血管画分
プロロセラピー
その他

第8章変形性関節症治療市場分析：適応疾患別

変形性膝関節症
変形性脊椎症
変形性足関節症
肩変形性関節症
手の変形性関節症
その他

第9章変形性関節症治療市場分析：エンドユーザー別

病院および診療所
専門クリニック
外来手術センター
在宅医療
その他

第10章変形性関節症治療市場：地域別分析

概要北米
- 北米
  - 米国
  - カナダ
  - メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- APACのその他諸国
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- その他中東とアフリカ
中南米
- ブラジル
- アルゼンチン
- その他中南米

第11章業界情勢

変形性関節症治療の世界市場における成長戦略
有機的開発
無機的展開

第12章企業プロファイル

Vision Quest Industries Inc
Dr PRP USA LLC
Estar Technologies Ltd
Zimmer Biomet Holdings Inc
DePuy Synthes Inc
Bioventus Inc
Omron Healthcare Inc
Exactech Inc
Medi GmbH & Co KG
Zealmax Innovations Pvt Ltd

第13章付録

図表

List Of Tables

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 16. Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 17. Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 19. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 20. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 22. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 23. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 24. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 25. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 26. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 28. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 29. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 30. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 32. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 33. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 34. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 35. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 36. Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 37. Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 38. Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 39. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 40. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 41. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 42. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 43. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 44. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 45. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 46. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 47. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 48. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 49. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 50. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 51. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 52. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 53. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 54. Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 55. Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 56. Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 57. Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 58. Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 59. Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 60. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 61. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 62. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 63. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 64. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 65. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 66. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 67. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 68. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 69. Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 70. Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 71. Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 72. South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 73. South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 74. South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 75. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 76. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 77. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 78. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 79. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 80. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 81. Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 82. Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 83. Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 84. Organic Developments Done by Companies
Table 85. Inorganic Developments Done by Companies

List Of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030
Figure 5. Osteoarthritis Therapy Market, By Geography Forecast Analysis, 2022 & 2030
Figure 6. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 7. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 14. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 21. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America: Osteoarthritis Therapy Market by Key Countries - Revenue (2022) US$ Million
Figure 27. North America Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. North America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 29. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)
Figure 33. Europe Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 35. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 41. Asia Pacific: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 42. Asia Pacific: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 44. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 45. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 46. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 47. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 48. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 49. Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 50. Middle East and Africa: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 51. Middle East and Africa: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 54. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 55. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 56. Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 57. South and Central America: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 58. South and Central America: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. South and Central America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 60. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 61. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 62. Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 63. Growth Strategies in the Global Osteoarthritis Therapy Market

Product Code: TIPRE00038936

The osteoarthritis therapy market size is projected to grow from US$ 17.36 billion in 2022 to US$ 30.68 billion by 2030; the market is estimated to record a CAGR of 7.4% during 2022-2030. The rising prevalence of osteoarthritis and innovative therapy options reducing dependency on medications are the key factors propelling the osteoarthritis therapy market development. However, product recall hamper the osteoarthritis therapy market growth. Furthermore, more effective treatment options to fuel osteoarthritis therapy acts as a lucrative market trend during the forecast period.

Growth Drivers:

Rising Prevalence of Osteoarthritis Drives Osteoarthritis Therapy Market Growth

Globally, OA affects more than 500 million people, accounting for 7% of the world's population, according to the CDC report. It represents a major cause of long-term disability. Osteoarthritis is more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases.

According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among the older population. Also, OA can affect anyone, but the condition is most commonly observed in adults aged 40 years and above. Also, the WHO report further reveals that about 73% of the population is older than 55 years and living with OA, among which 60% are female. According to the Centers for Disease Control and Prevention (CDC) report, over 32.5 million adults in the US are affected by OA. Thus, with the rising prevalence of OA and, new therapy options, such as biological therapy, are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising OA treatment. PRP enhances tissue recovery by catalyzing the body's natural healing and tissue repair processes.

Report Segmentation and Scope:

The osteoarthritis therapy market is segmented into therapy type, disease indication, and end user. Based on therapy type, the market is segmented into Transcutaneous Electrical Nerve Stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy and stromal vascular fraction, prolotherapy, and others. The market is segmented by disease indication into knee osteoarthritis, spine osteoarthritis, foot & ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. In terms of end-users, the market is segmented into hospitals & clinics, specialty clinics, ambulatory surgical centers (ASCs), homecare, and others.

Therapy Type-Based Insights

By therapy type, the osteoarthritis therapy market is segmented as transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma and stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The others segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The other segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. Physical therapies, such as yoga, help improve physical function in patients affected by knee osteoarthritis. The clinical study reveals that the patients suffering from knee osteoarthritis receiving physical therapy (PT) have gained more quality-adjusted life-years than those receiving glucocorticoid injections. Additionally, physical therapy is clinically more effective than glucocorticoid injection; moreover, it is perceived as a more cost-effective option.

The other segment is estimated to register the highest CAGR for the osteoarthritis therapy market. Another therapy is rehabilitation therapy for osteoarthritis. The rehabilitation program is designed to reduce pain and increase functionality quickly. The rehabilitation's main goal is to relieve knee OA symptoms and slow its progression. The future perspective and rehabilitation include nonpharmacological management of OA followed by exercise, which effectively improves the quality of life, joint function, muscle power, strength, and functional performance. Therefore, modifications in rehabilitation programs will ultimately reduce the patients' osteoarthritis pain, bolstering the osteoarthritis therapy market growth during the forecast period.

Disease Based Insights

The knee osteoarthritis segment held the largest market share of the osteoarthritis therapy market by disease indication segment in 2022, and the same segment is anticipated to grow at the fastest CAGR of 7.7% during the forecast period. According to the National Academy of Science report, knee osteoarthritis (KO) accounts for more than 80% of the total disease burden, affecting nearly 19% of American adults aged 45 years and above annually. Launches of innovative products by manufacturers can help reduce the burden of knee osteoarthritis. In September 2021, Contura International Ltd announced a new product launch, "Arthrosamid," an alternative to current therapy that fulfills an unmet clinical need for a safe, effective, long-acting, and minimally invasive treatment for alleviating pain associated with knee OA. Therefore, the rising prevalence of knee OA and innovative product launches to minimize osteoarthritis pain drive the osteoarthritis therapy market growth.

End User-Based Insights

The homecare segment held the largest market share of the osteoarthritis therapy market by end-user segment in 2022. Additionally, the hospitals & clinics segment is estimated to register the highest CAGR of 7.5% during the forecast period. The first and foremost remedy to overcome arthritis is reducing excess body weight. Additionally, hot and cold therapies can bring back flexibility in stiff joints, which can help reduce joint pain. The use of electric blankets or moist heating pads proves helpful in reducing pain. However, cold treatments such as packs of ice or bags of frozen vegetables can be applied to the affected joints, giving relief. Availability of such treatment options proves to be a successful remedy for managing osteoarthritis at home, which drives the osteoarthritis therapy market growth for the homecare segment.

Regional Analysis:

Based on geography, the global osteoarthritis therapy market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest global osteoarthritis therapy market share. Asia Pacific is expected to register the highest CAGR during 2022-2030. In the North American market, the US accounts for the largest market share of the osteoarthritis therapy market. According to the statistics revealed in the Centers for Disease Control and Prevention (CDC) report, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million adults in the US. Additionally, the Osteoarthritis (OA) Action Alliance report reveals that the overall economic burden associated with OA in the US is estimated at US$ 136.8 billion annually. Further, the American Roentgen Ray Society ARRS report reveals that the lifetime risk of OA is 50%, and it is estimated that by 2040, ~78 million (26%) adults in the country will have OA.

Further, new product approvals by the manufacturers aiming for non-pharmacology therapy for OA pain influence the osteoarthritis therapy market growth. In June 2021, CyMedica Orthopedics announced receiving FDA approval for the "Intellihab System," a noninvasive modality for knee osteoarthritis pain. The new product launch is a therapeutic and digital-based ecosystem that is designed to treat OA pain with a debilitating osteoarthritis disease. Therefore, new non-pharmacology therapy intended to reduce dependency on therapeutics in OA treatment would fuel the growth of the osteoarthritis therapy market during the forecast period.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 PEST Analysis
4.2 Pipeline Analysis
- 4.2.1 Clinical Trial Pipeline Analysis

5. Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Osteoarthritis Therapy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Osteoarthritis
- 5.2.2 Innovative Therapy Options Reducing Dependency on Medications
5.3 Market Restraints
- 5.3.1 Product Recall
5.4 Market Opportunities
- 5.4.1 Availability of Regenerative Medicine
5.5 Future Trends
- 5.5.1 More Effective Treatment Options
5.6 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Global Market Analysis

6.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030
- 6.1.1 Overview
- 6.1.2 Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030

7. Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Osteoarthritis Therapy Market - Geographical Analysis

10.1 Overview North America
- 10.1.1 North America Osteoarthritis Therapy Market Overview
- 10.1.2 North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.2.1 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.1.2.2 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.1.2.3 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.1.3 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.1.1 Overview
    - 10.1.3.1.2 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.3.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.3.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.3.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.2.1 Overview
    - 10.1.3.2.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.3.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.3.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.3.3 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.3.1 Overview
    - 10.1.3.3.2 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.3.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.3.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User
10.2 Europe
- 10.2.1 Europe Osteoarthritis Therapy Market Overview
- 10.2.2 Europe: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)
  - 10.2.2.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.2.2.2 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.2.2.3 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.2.3 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.1.1 Overview
    - 10.2.3.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.2.1 Overview
    - 10.2.3.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.3.1 Overview
    - 10.2.3.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.4.1 Overview
    - 10.2.3.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.5.1 Overview
    - 10.2.3.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.6.1 Overview
    - 10.2.3.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User
10.3 Asia Pacific
- 10.3.1 Asia Pacific Osteoarthritis Therapy Market Overview
- 10.3.2 Asia Pacific: Osteoarthritis Therapy Market
  - 10.3.2.1 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.3.2.2 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.3.2.3 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.1.1 Overview
    - 10.3.3.1.2 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.1.3 China: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.1.4 China: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.1.5 China: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.2.1 Overview
    - 10.3.3.2.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.2.3 Japan: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.2.4 Japan: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.2.5 Japan: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.3 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.3.1 Overview
    - 10.3.3.3.2 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.3.3 India: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.3.4 India: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.3.5 India: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.4 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.4.1 Overview
    - 10.3.3.4.2 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.4.3 Australia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.4.4 Australia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.4.5 Australia: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.5 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.5.1 Overview
    - 10.3.3.5.2 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.5.3 South Korea: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.5.4 South Korea: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.5.5 South Korea: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.6 Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.6.1 Overview
    - 10.3.3.6.2 Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.6.3 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.6.4 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.6.5 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by End User
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Osteoarthritis Therapy Market Overview
- 10.4.2 Middle East and Africa: Osteoarthritis Therapy Market
  - 10.4.2.1 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.4.2.2 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.4.2.3 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.1.1 Overview
    - 10.4.3.1.2 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.4.3.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.4.3.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.4.3.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.2.1 Overview
    - 10.4.3.2.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.4.3.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.4.3.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.4.3.3 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.3.1 Overview
    - 10.4.3.3.2 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.4.3.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.4.3.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.4.3.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.4.1 Overview
    - 10.4.3.4.2 Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.4.3 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.4.3.4.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.4.3.4.5 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.5 South and Central America
- 10.5.1 South and Central America Osteoarthritis Therapy Market Overview
- 10.5.2 South and Central America: Osteoarthritis Therapy Market
  - 10.5.2.1 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.5.2.2 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.5.2.3 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.5.3 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.1.1 Overview
    - 10.5.3.1.2 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.1.3 Brazil: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.5.3.1.4 Brazil: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.5.3.1.5 Brazil: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.5.3.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.2.1 Overview
    - 10.5.3.2.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.2.3 Argentina: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.5.3.2.4 Argentina: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.5.3.2.5 Argentina: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.5.3.3 Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.3.1 Overview
    - 10.5.3.3.2 Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.3.3 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.5.3.3.4 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.5.3.3.5 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Global Osteoarthritis Therapy Market
11.3 Organic Developments
- 11.3.1 Overview
11.1 Inorganic Developments
- 11.1.1 Overview

12. Company Profiles

12.1 Vision Quest Industries Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Dr PRP USA LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Estar Technologies Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Zimmer Biomet Holdings Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 DePuy Synthes Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bioventus Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Omron Healthcare Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Exactech Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Medi GmbH & Co KG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Zealmax Innovations Pvt Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

変形性関節症治療 - 市場規模と予測、世界および地域のシェア、動向、成長機会分析レポート：治療タイプ別、適応疾患別、エンドユーザー別、地域別

Osteoarthritis Therapy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, Disease Indication, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章変形性関節症治療市場情勢

第5章変形性関節症治療市場- 主な市場力学

第6章変形性関節症治療市場：世界市場分析

第7章変形性関節症治療市場分析：治療タイプ別

第8章変形性関節症治療市場分析：適応疾患別

第9章変形性関節症治療市場分析：エンドユーザー別

第10章変形性関節症治療市場：地域別分析

第11章業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Osteoarthritis Therapy Market Landscape

5. Osteoarthritis Therapy Market - Key Market Dynamics

6. Osteoarthritis Therapy Market - Global Market Analysis

7. Osteoarthritis Therapy Market Analysis - by Therapy Type

8. Osteoarthritis Therapy Market Analysis - by Disease Indication

9. Osteoarthritis Therapy Market Analysis - by End User

10. Osteoarthritis Therapy Market - Geographical Analysis

11. Industry Landscape

12. Company Profiles

13. Appendix

変形性関節症治療 - 市場規模と予測、世界および地域のシェア、動向、成長機会分析レポート：治療タイプ別、適応疾患別、エンドユーザー別、地域別

Osteoarthritis Therapy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, Disease Indication, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 変形性関節症治療市場情勢

第5章 変形性関節症治療市場- 主な市場力学

第6章 変形性関節症治療市場：世界市場分析

第7章 変形性関節症治療市場分析：治療タイプ別

第8章 変形性関節症治療市場分析：適応疾患別

第9章 変形性関節症治療市場分析：エンドユーザー別

第10章 変形性関節症治療市場：地域別分析

第11章 業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Osteoarthritis Therapy Market Landscape

5. Osteoarthritis Therapy Market - Key Market Dynamics

6. Osteoarthritis Therapy Market - Global Market Analysis

7. Osteoarthritis Therapy Market Analysis - by Therapy Type

8. Osteoarthritis Therapy Market Analysis - by Disease Indication

9. Osteoarthritis Therapy Market Analysis - by End User

10. Osteoarthritis Therapy Market - Geographical Analysis

11. Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章変形性関節症治療市場情勢

第5章変形性関節症治療市場- 主な市場力学

第6章変形性関節症治療市場：世界市場分析

第7章変形性関節症治療市場分析：治療タイプ別

第8章変形性関節症治療市場分析：適応疾患別

第9章変形性関節症治療市場分析：エンドユーザー別

第10章変形性関節症治療市場：地域別分析

第11章業界情勢

第12章企業プロファイル

第13章付録